American Journal of Analytical Chemistry

Volume 6, Issue 5 (April 2015)

ISSN Print: 2156-8251   ISSN Online: 2156-8278

Google-based Impact Factor: 1.71  Citations  h5-index & Ranking

HPLC Method Development and Validation of S(-)-Carvedilol from API and Formulations

HTML  Download Download as PDF (Size: 1957KB)  PP. 437-445  
DOI: 10.4236/ajac.2015.65043    4,158 Downloads   5,946 Views  Citations

ABSTRACT

A simple chiral HPLC method was developed and validated for quantification of S(-)-Carvedilol in Active Pharmaceutical Ingredient (API) and marketed tablet formulation of racemic Carvedilol. Chiral resolution of enantiomers of Carvedilol was achieved on Phenomenex Lux-cellulose–4 (250 mm × 4.6 mm; 5 μ particle size) chiral column by using a mobile phase, Isopropanol and n-Heptane (60:40 v/v), at a flow rate of 1.0 ml/min and by employing UV detection at 254 nm wavelength. The method was validated according to the ICH guidelines and was proved to be specific, linear, precise and accurate for the analysis of S(-)-Carvedilol.

Share and Cite:

Swetha, E. , Vijitha, C. and Veeresham, C. (2015) HPLC Method Development and Validation of S(-)-Carvedilol from API and Formulations. American Journal of Analytical Chemistry, 6, 437-445. doi: 10.4236/ajac.2015.65043.

Cited by

[1] Three spectrophotometric approaches for measuring ratio spectra of Ivabradine and Carvedilol in a binary mixture using green analytical principles
Current Chemistry Letters, 2022
[2] Sustainable Analytical Method Development Validation of Selective Cardiovascular Drugs by UV Spectrophotometry and Aqbd Based LC Techniques for Tablets and …
2022
[3] A Comparative Review of Methods For Estimation of Some Antihypertensive Drugs in Pharmaceutical Production
Egyptian Journal of …, 2021
[4] Development and Validation of a Rapid Analytical Method for the Simultaneous Quantification of Metabolic Syndrome Drugs by HPLC-DAD Chromatography
2021
[5] Separation of Carvedilol Enantiomers using HPLC by two Different Methods: Mobile Phase Chiral Additive and Chiral Stationary Phase
2020
[6] Effectiveness of acupressure on bio-physiological parameters in mediosternotomy patients
2019
[7] Temperature and eluent composition effects on enantiomer separation of carvedilol by high‐performance liquid chromatography on immobilized amylose …
2019
[8] Quality Assessment of Some Commonly Used Enantiomeric Drugs in Bangladesh
2019
[9] Development and validation of UPLC method for simultaneous quantification of carvedilol and ivabradine in the presence of degradation products using DoE concept
Journal of Liquid Chromatography & Related Technologies, 2018
[10] Formulation, optimization and in vitro evaluation of lipid nanoparticles Containing anti-hypertensive drug
2018
[11] DEVELOPMENT OF FIRST ORDER AND SECOND ORDER DERIVATIVE FLUOROMETRIC METHODS FOR CARVEDILOL IN BULK AND FORMULATIONS
International Journal of Pharma And Chemical Research, 2018
[12] Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
2017
[13] Enantioselective Resolution of (R, S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
Natural Products and Bioprospecting, 2017
[14] DEVELOPMENT AND VALIDATION OF A RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF CARVEDILOL, GLIMEPIRIDE OR GLIBENCLAMIDE IN BINARY COMBINATIONS; AND ITS APPLICATION FOR IN VITRO-INTERACTION STUDIES
Indo American Journal of Pharmaceutical Research, 2015
[15] development and validation of a RP-HPLC method for the simultaneous determination of carvedilol, glimepiride or glibenclamide in binary combinations; and its …
2015
[16] development and validation of a RP-HPLC method for the simultaneous determination of carvedilol, glimepiride or glibenclamide in binary combinations; …
2015
[17] Analytical Technique for Carvedilol and Ivabradine Determination from Pure and Pharmaceutical Dosage Forms: A Review

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.